Levi & Korsinsky, LLP is investigating Northwest Biotherapeutics, Inc.
("Northwest Bio" or the "Company") (NasdaqCM: NWBO) in connection with
possible breaches of federal securities laws. The investigation regards
concerns that the Company made misleading statements regarding its
clinical trial for DC-Vax Direct, its experimental cancer vaccine.
To get more information, click here: http://zlk.9nl.com/northwest-biotherapeutics-nbo.
There is no cost or obligation to you.
On June 19, 2014, an article featured on TheStreet.com alleged that the
MD Anderson Cancer Center had "issued a stern rebuke to Northwest
Biotherapeutics for making promotional, unjustified claims about
results" from the ongoing drug trial.
If you own common stock in Northwest Bio and wish to obtain additional
information, please contact Eduard Korsinsky, Esq. either via email at email@example.com
or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/northwest-biotherapeutics-nwbo.
Levi & Korsinsky is a national firm with offices in New York, New
Jersey, Connecticut and Washington D.C. The firm's 26 attorneys have
extensive expertise in prosecuting securities litigation involving
financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits. For more information, please feel
free to contact any of the attorneys listed below. Attorney advertising.
Prior results do not guarantee similar outcomes.
[ Back To NFVZone's Homepage ]